<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Specific Aims (Phase I) v3</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="PromptGenix SBIR Phase I Specific Aims v3 (compressed for 1 page): significance, innovation, objective, aims, outcomes, impact."/>
  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.45;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    /* Shared header/nav */
    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }
    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }
    .section{
      max-width: 980px;
      margin: 0 auto;
      padding: 28px 20px;
    }
    .topline{
      display:flex; flex-wrap:wrap; gap:10px;
      align-items:center; justify-content:space-between;
      padding-top: 16px;
      margin-bottom: 10px;
    }
    .doc-title{
      font-size: 1.18rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 0;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
    }

    h2{
      font-size: .86rem;
      letter-spacing: .14em;
      text-transform: uppercase;
      color:#a5b4fc;
      margin: 14px 0 6px;
    }
    p{
      margin: 0 0 8px;
      font-size: .92rem;
      color:#d1d5db;
    }
    .box{
      margin: 8px 0 10px;
      border-radius: 14px;
      padding: 10px 12px;
      border: 1px solid rgba(148,163,184,0.35);
      background: rgba(15,23,42,0.75);
    }
    .box strong{ color:#22c55e; }

    ul{
      margin: 6px 0 8px;
      padding-left: 1.1rem;
      color:#d1d5db;
      font-size: .92rem;
    }
    li{ margin-bottom: 4px; }

    .fine{
      font-size:.78rem;
      color:#9ca3af;
      margin-top: 8px;
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    /* PRINT CONFIG (SBIR – 1 page) */
    @media print {
      @page { size: Letter; margin: 0.5in; }
      header, footer { display: none !important; }

      body {
        background:#fff !important;
        color:#111 !important;
        font-size: 11.0pt;
        line-height: 1.26;
        -webkit-print-color-adjust: exact;
        print-color-adjust: exact;
      }
      .section { max-width: 100% !important; padding: 0 !important; margin: 0 !important; }
      p, li { color:#111 !important; margin-bottom: 3px !important; }
      h2 { color:#111 !important; margin-top: 10px !important; margin-bottom: 4px !important; }
      .doc-title { color:#111 !important; }
      .meta { color:#333 !important; }
      .box { background:#fff !important; border:1px solid #999 !important; padding: 7px 8px !important; }
      a { color:#111 !important; text-decoration:none !important; }

      /* prevent awkward splits */
      h2, .box { break-after: avoid-page; page-break-after: avoid; }
      p, li { orphans: 2; widows: 2; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html" class="active">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">
      <div class="topline">
        <h1 class="doc-title">Specific Aims (Phase I): PromptGenix – Hypothesis Intelligence Engine for Public Biomedical Data (v3)</h1>
        <div class="meta">
          PromptGenix LLC (Women &amp; Minority-Owned) &middot; Contact: dohoon.kim1@icloud.com &middot;
          Website: promptgenix.org/sbir.html
        </div>
      </div>

      <h2>Significance</h2>
      <p>
        Public biomedical resources contain vast omics/immune profiling datasets and a rapidly expanding literature,
        yet a key bottleneck remains: converting heterogeneous evidence into <strong>prioritized, testable hypotheses</strong>
        with <strong>quantified uncertainty</strong>. Fragmented tools and bespoke scripts slow turnaround and reduce reproducibility,
        while interpretation depends on scarce expert time. What is missing is a scalable, transparent mechanism for
        evidence-weighted scientific synthesis and decision support.
      </p>

      <h2>Innovation</h2>
      <p>
        PromptGenix introduces a <strong>hypothesis intelligence engine</strong> that prioritizes mechanistic hypotheses using
        statistical evidence modeling and Bayesian updating over public biomedical data and literature-derived priors.
        LLMs are constrained to <strong>interpretability</strong> (explaining rankings, summarizing evidence, citing sources) rather than
        determining confidence. Unlike tools that produce plots or narrative summaries alone, PromptGenix delivers
        <strong>evidence-linked hypothesis rankings</strong> with explicit uncertainty labeling and actionable next steps.
      </p>

      <h2>Overall objective &amp; central hypothesis</h2>
      <div class="box">
        <p><strong>Objective:</strong> Deliver a validated Phase I prototype that retrieves public datasets and literature,
          constructs standardized evidence objects, and outputs ranked biological hypotheses with probabilistic confidence,
          traceable evidence links, and recommended follow-up experiments.</p>
        <p><strong>Central hypothesis:</strong> An evidence-weighted decision engine combining statistical scoring/Bayesian inference with
          constrained LLM interpretability will reduce time-to-hypothesis while improving transparency, reproducibility,
          and usefulness for study design decisions in immunology and infectious disease research.</p>
      </div>

      <h2>Specific aims</h2>
      <ul>
        <li><strong>Aim 1.</strong> Build a robust public-data ingest and evidence feature layer that generates standardized evidence objects
          (effect sizes, uncertainty-aware descriptors, reproducibility checks, context) from selected datasets and metadata.</li>
        <li><strong>Aim 2.</strong> Implement an evidence-weighted hypothesis prioritization engine using statistical scoring and Bayesian updating
          to compute posterior confidence and rank candidate hypotheses with explicit uncertainty annotations.</li>
        <li><strong>Aim 3.</strong> Deliver reviewer-ready HTML/PDF outputs and evaluate usability via 2–3 pilot studies, measuring traceability,
          rerun reproducibility, turnaround time, and “useful” ratings for hypothesis recommendations.</li>
      </ul>

      <h2>Expected outcomes &amp; deliverables</h2>
      <ul>
        <li>Deterministic, reproducible evidence objects and ranked hypotheses across reruns (versioned configs, checksums, traceable artifacts).</li>
        <li>Evidence-linked hypotheses with posterior confidence estimates and clear support vs. conflict coverage.</li>
        <li>Reviewer-ready reports generated within &lt;24 hours for accession-driven runs (dataset-dependent), with reduced manual synthesis time.</li>
      </ul>

      <h2>Impact</h2>
      <p>
        Successful completion of Phase I will de-risk Phase II development of a scalable hypothesis intelligence platform for faster,
        more transparent evidence integration and prioritization—supporting, not replacing, human scientific decision-making.
      </p>

      <div class="fine">
        Phase I SBIR – NIH/NIAID focus &middot; Public-data validation &middot; Women &amp; Minority-Owned Small Business
      </div>
    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot;
    <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
